Who Is Eligible for — Bevacizumab?
Your oncologist has prescribed bevacizumab, and you want to understand why it applies to you and not everyone else. Eligibility is based on your cancer type and your general health — not a biomarker test. Knowing what was checked helps you ask the right questions at your next appointment.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- No biomarker test required — Bevacizumab does not need PD-L1, MSI or TMB testing. Your cancer type and stage decide whether it applies.
- Approved for several cancer types — It is used in colorectal, ovarian, cervical, and non-squamous lung cancer, and in glioblastoma.
- Health history matters too — Uncontrolled high blood pressure, recent surgery, or a history of serious bleeding can rule it out.
- Given as a day-care infusion — Bevacizumab is usually given alongside chemotherapy through an IV drip, not as a tablet taken at home.
on Panel
Survival Rate*
Treated
(800+ reviews)
Bevacizumab is used in specific cancer types — including colorectal, ovarian, cervical, non-squamous lung cancer, and glioblastoma — and does not require a biomarker test before it is prescribed. Whether you are suitable also depends on your general health, especially your blood pressure, wound-healing history, and any planned surgery.
How does your oncologist decide whether bevacizumab suits you?
Bevacizumab works differently from immunotherapy or targeted therapies that need a specific gene mutation to be present. There is no PD-L1 score, no MSI result, and no gene panel to wait for.
The first question is whether your cancer type is one where bevacizumab is part of the standard treatment approach. The second question is whether your general health — particularly blood pressure, wound healing, and clotting history — makes it safe to use.
If your oncologist has recommended it, both of those questions have already been considered.
Which cancer types is bevacizumab used for?
- Metastatic colorectal cancerGiven alongside chemotherapy, typically from the start of treatment for metastatic disease.
- Non-squamous non-small cell lung cancerOnly non-squamous histology — squamous cell type carries a different risk profile.
- Ovarian, fallopian tube, and peritoneal cancerUsed in advanced and relapsed disease, combined with chemotherapy.
- Cervical cancerIn recurrent or advanced disease, given alongside chemotherapy.
- GlioblastomaAn aggressive brain tumour; used when it recurs after initial treatment.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What health conditions can rule bevacizumab out?
Bevacizumab affects how blood vessels form and how wounds heal, which means certain conditions make it unsafe to use.
Recent major surgery is one of them. Your team will plan a gap between any operation and your bevacizumab infusions — both before and after surgery — to protect wound healing.
High blood pressure that is not well controlled, a history of serious bleeding, a history of arterial blood clots such as a stroke or heart attack, and pregnancy can also mean bevacizumab is not the right choice. Your oncologist will review your medical history specifically to check for these before treatment starts.
Did you know?
Bevacizumab works by blocking a protein called VEGF, which tumours use to grow new blood vessels for themselves.
Without that blood supply, tumours are less able to grow and spread — which is why this class of drug is called anti-angiogenic.
Source: NCCN Clinical Practice Guidelines in Oncology
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Does bevacizumab need a biomarker test before I can have it?
No. Unlike immunotherapy, which needs PD-L1, MSI or TMB results from your tumour tissue, bevacizumab does not require biomarker testing. Your oncologist decides whether it is appropriate based on your cancer type, stage, and health history. If you have heard about biomarker testing in the context of your treatment, ask your team specifically which tests apply to you — the answer depends on which treatments are being considered.
Can I have bevacizumab if I have high blood pressure?
High blood pressure that is well controlled is usually manageable, and your team will monitor it closely throughout treatment. Bevacizumab can raise blood pressure further, so if yours is already difficult to control, your oncologist will weigh that risk carefully before proceeding. Tell your team about every blood pressure medication you take, including anything prescribed by a doctor outside your oncology team.
Why is bevacizumab not used for squamous cell lung cancer?
Squamous cell lung tumours tend to sit close to large blood vessels in the central chest. Bevacizumab affects blood vessel walls, and in squamous cell histology that combination carries a risk of serious bleeding that is considered too high. Non-squamous types — such as adenocarcinoma — have a different anatomy and a more acceptable risk profile. Your pathology report determines which type you have, and your oncologist will explain what that means for your options.
Will I need to stop bevacizumab before surgery?
Yes. Because bevacizumab slows wound healing, your treatment is paused around any surgical procedure — usually for several weeks before and after the operation. This applies to planned operations of all kinds, including procedures under general anaesthetic. Tell your oncology team about any planned surgery as early as possible so the timing can be managed safely, and do not assume a minor procedure is too small to mention.
Is bevacizumab given on its own or alongside chemotherapy?
In most settings it is given alongside chemotherapy rather than as a standalone treatment. It works by cutting off the blood supply a tumour builds for itself, while chemotherapy acts on the cancer cells directly — the two approaches are intended to work together. The specific chemotherapy regimen depends on your cancer type. Your oncologist will explain the combination being planned for you and what to expect from each part of it.
Is this treatment available at CION?
Infusion-based cancer treatment is available as day care at CION centres — you come in for your infusion and go home the same day. Ask your care team which centre handles your treatment and what to bring on infusion day. If your care plan also includes scans such as PET-CT, those are coordinated with partner imaging centres.